MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 108 filers reported holding MEI PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,939 | -65.6% | 47,769 | -64.0% | 0.00% | – |
| Q4 2022 | $31,844 | +32.7% | 132,684 | +115.0% | 0.00% | – |
| Q3 2022 | $24,000 | – | 61,725 | +18380.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 334 | -95.1% | 0.00% | – |
| Q1 2022 | $4,000 | -96.2% | 6,834 | -82.6% | 0.00% | – |
| Q4 2021 | $106,000 | +10500.0% | 39,337 | +8027.5% | 0.00% | – |
| Q3 2021 | $1,000 | -90.9% | 484 | -87.0% | 0.00% | – |
| Q2 2021 | $11,000 | -85.3% | 3,709 | -83.0% | 0.00% | – |
| Q1 2021 | $75,000 | -27.2% | 21,823 | -44.1% | 0.00% | – |
| Q4 2020 | $103,000 | +5050.0% | 39,061 | +6705.1% | 0.00% | – |
| Q3 2020 | $2,000 | -98.6% | 574 | -98.3% | 0.00% | – |
| Q2 2020 | $143,000 | +49.0% | 34,718 | -41.9% | 0.00% | – |
| Q1 2020 | $96,000 | -59.8% | 59,722 | -38.0% | 0.00% | – |
| Q4 2019 | $239,000 | +139.0% | 96,370 | +60.9% | 0.00% | – |
| Q3 2019 | $100,000 | +203.0% | 59,877 | +358.4% | 0.00% | – |
| Q2 2019 | $33,000 | +57.1% | 13,062 | +83.6% | 0.00% | – |
| Q1 2019 | $21,000 | +600.0% | 7,116 | +606.0% | 0.00% | – |
| Q4 2018 | $3,000 | -57.1% | 1,008 | -43.8% | 0.00% | – |
| Q3 2018 | $7,000 | +40.0% | 1,794 | +36.8% | 0.00% | – |
| Q2 2018 | $5,000 | +150.0% | 1,311 | +30.1% | 0.00% | – |
| Q1 2018 | $2,000 | -50.0% | 1,008 | -42.5% | 0.00% | – |
| Q4 2017 | $4,000 | -71.4% | 1,752 | -66.7% | 0.00% | – |
| Q3 2017 | $14,000 | +600.0% | 5,269 | +422.7% | 0.00% | – |
| Q2 2017 | $2,000 | -50.0% | 1,008 | -58.8% | 0.00% | – |
| Q1 2017 | $4,000 | +300.0% | 2,445 | +138.5% | 0.00% | – |
| Q4 2016 | $1,000 | -87.5% | 1,025 | -76.2% | 0.00% | – |
| Q3 2016 | $8,000 | +700.0% | 4,305 | +327.1% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 1,008 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 1,008 | -12.0% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 1,146 | -5.1% | 0.00% | – |
| Q3 2015 | $2,000 | -50.0% | 1,207 | -53.1% | 0.00% | – |
| Q2 2015 | $4,000 | +100.0% | 2,576 | +113.4% | 0.00% | – |
| Q1 2015 | $2,000 | -33.3% | 1,207 | +90.4% | 0.00% | – |
| Q4 2014 | $3,000 | – | 634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |